biorica.biz

Biorica is a Swiss biotechnology company dedicated to the discovery and development of next-generation targeted therapies for oncology. Spun out from the Institute of Oncology Research (IOR), the company utilizes a proprietary platform to identify and exploit specific molecular vulnerabilities in cancer cells, particularly those related to cellular senescence and tumor microenvironment interactions. Biorica's lead programs focus on treating advanced solid tumors, including prostate cancer, by delivering potent therapeutic agents directly to malignant tissues while sparing healthy cells. The company aims to transform the standard of care for patients with limited treatment options through its precision medicine approach.